2TANTIVE JKUL K, VUCENIK I, SHAMSUDDIN A M. Inositol hexaphosphate (IP6) inhibits key events of cancer me- tastasis: ]I. Effects on integrins and focal adhesions [J], Anti- cancer Res, 2003,23 (5A) :3681-3689. SINGH R P, AGARWAL R. Prostate cancer and inositol hexaphosphate: efficacy and mechanisms [J]. Anticaneer Res, 2005,25(4) :2891-2903.
3MALVASI A, CASCIARO F, inositol, D-chiro-inositol, folic MINERVINI MM, et al. Myo- acid and mahganese in second trimester of pregnancy: a preliminary investigation [J]. Eur Rev Med Pharraaeol Sei, 2014,18 (2) 270-274.
4LAM S, MVWILLIAMS A, LERICHE J. A phase I study of myo-inositol for lung cancer chemoprevention[J]. Cancer Epi- demiol Biomarkers Prey, 2006,15(8) : 1526-1531.
5IVAN B, NIKICA D, ROBERT K, et al. Efficacy of IP6+ inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study [J]. J Exp Clin Cancer Res, 2010,29(1):12.
6AMBROSINI G, ADIDA C, ALTIERI DC. A novel anti-apop- tosis gene, survivin, expressed in cancer and lymphoma[J]. Nat Med, 1997,3(8) :917-921.
7HALL P A, LEVISON D A, WOODS A L. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sec- tions; an index of cell proliferation with evidence of deregula- ted expression in some neoplasms [J]. J PatIaol, 1990,162(4) : 285-294.
8DIERENDONCK J H. WIJSMAN J U, KEIJZER R, et al. Cell-cycle-related staining patterns of antiprol ferating cell nu- clear antigen monoclonal antibodies. Comparison with Brd Urd labeling and Ki-67 staining[J]. Am J Pathol, 1991,138 (5) 1165.
